A Study of transplantation of allogenic induced pluripotent stem cell (iPSC) derived retinal pigment epithelium (RPE) cell suspension in subjects with neovascular age related macular degeneration - Transplantation of allogenic iPSC derived RPE cell suspension in subject with neovascular AMD

Kobe City Eye Hospital0 个研究点目标入组 5 人开始时间: 2017年2月6日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1)-4) applicable only in subject eye) 1) Ocular infection 2) Other retinal disease (diabetic retinopathy, hypertensive retinopathy, vascular occlusion, etc.) 3) Optic nerve atrophy 4) Glaucoma with poorly controled intraocular pressure 5) Severe liver dysfunction (AST/ALT 100 IU/L or higher) 6) Severe renal impairment that require dialysis 7) Hepatitis B virus, Hepatitis C virus, Human Immunodeficiency Virus, Adult T-cell Leukemia Virus, cases of Syphilis-positive 8) Allergic to bovine serum or antibiotics (penicillin, streptomycin) 9) Unable to quit anti-coagulants or anti-platelet medication 10) Malignant carcinoma (except for carcinoma in situ) or its history in the past 3 years 11) Allergic to fluorescein or indocyanine green angiography 12) Possible pregnancy or with the partner having a wish for pregnancy 13) Enrolled in another clinical study in the past 1 month 14) Judged unsuitable for study participation by the principal investigator or co-investigators

发起方

Kobe City Eye Hospital